Apolipoprotein and LRP1-Based Peptides as New Therapeutic Tools in Atherosclerosis

Apolipoprotein and LRP1-Based Peptides as New Therapeutic Tools in Atherosclerosis

Apolipoprotein (Apo)-based mimetic peptides have been shown to reduce atherosclerosis. Most of the ApoC-II and ApoE mimetics exert anti-atherosclerotic effects by improving lipid profile. ApoC-II mimetics reverse hypertriglyceridemia and ApoE-based peptides such as Ac-hE18A-NH2 reduce cholesterol an...

Full description

Bibliographic Details
Main Authors: Aleyda Benitez Amaro, Angels Solanelles Curco, Eduardo Garcia, Josep Julve, Jose Rives, Sonia Benitez, Vicenta Llorente Cortes
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Journal of Clinical Medicine
Subjects:
apolipoproteins
atherosclerosis
clinical trials
LDL
peptides
Online Access:https://www.mdpi.com/2077-0383/10/16/3571

Internet

https://www.mdpi.com/2077-0383/10/16/3571

Similar Items